Few drugs have ever gained market-share, acceptance, and even enthusiastic use as rapidly as intravitreal Avastin has over the past year. This feat is particularly remarkable since its use is strictly "off-label". One reason for Avastin's rapid acceptance is its apparent similarity to Lucentis....